New Zealand markets open in 2 hours 20 minutes

MRNA Sep 2022 70.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.10000.0000 (0.00%)
As of 09:43AM EDT. Market open.
Full screen
Previous close0.1000
Expiry date2022-09-16
Day's range0.1000 - 0.1000
Contract rangeN/A
Open interest704
  • Editor's pick
    Yahoo Finance

    U.S. to end purchase of COVID-19 vaccines as industry pivots to commercial market

    Vaccines, treatments and tests will soon all be commercially available. But what that means for consumers' out-of-pocket costs is unclear.

  • Zacks

    Biotech Stock Roundup: GILD's Drug News, NVAX & MRNA COVID-19 Vaccine Updates

    Regulatory and pipeline updates from Gilead (GILD) and Moderna (MRNA) are a few key highlights from the biotech sector during the past week.

  • Motley Fool

    Has Moderna Made a Bear Market Blunder?

    In the past 12 months, shares of healthcare company Moderna (NASDAQ: MRNA) have fallen by more than 55% (the S&P 500 is down just 4% over that stretch). Although the company has generated billions from its COVID-19 vaccine, investors are getting more concerned about what the future looks like for the company beyond just COVID. Moderna has been sitting on billions in cash that could go a long way in investing in its business or even acquiring another company to expand its reach.